Biotechnology Value Fund

Biotechnology Value Fund

$181,700,000 IPO
PE HUB

Phathom Pharmaceuticals goes public

$400,000,000 Venture capital (Series C)
FinSMEs , PE HUB , VentureBeat

Relay Therapeutics Secures $400M in Series C Financing

$18,400,000 Venture capital (Series A)
MedCity News

Rain Therapeutics scores $18 million Series A round for lung cancer drug

$35,000,000 Venture capital (Series B)
PE HUB , Venture Funding News

ViewPoint Therapeutics attracts $35 mln Series B

Messaging
$75,000,000 Venture capital (Series A)
Xconomy , FinSMEs

Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech

Health Funding Science
$60,000,000 Post-IPO equity
bizjournals , 512tech

https://www.bizjournals.com/austin/news/2017/08/16/austin-biotech-company-lands-on-nasdaq-with-fresh.html?ana=twt

PE HUB

WCAS sells Aptuit to Evotec for about $300 mln

Strategy Apps & Services
PE HUB

Welsh Carson to exit Aptuit

Messaging
€90,300,000 Post-IPO equity
GEN

Evotec Attracts €90.3M Investment from Novo A/S Genetic Engineering & Biotechnology News - Biotech from Bench to Busines...

PE HUB

Vividion Therapeutics picks up $50 mln Series A

Funding Messaging
$50,000,000 Venture capital (Series A)
businesswire

Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing

$125,000,000 Post-IPO debt
Twitter

Biotech Day on Twitter

Xconomy

New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion

Robotics Science Health Intelligent machines
$4,000,000 Venture capital (Series A)
FinSMEs

ViewPoint Therapeutics Closes $4M Series A Financing

Funding Health
Xconomy

Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy

Health Science